Psychedelics are transforming the landscape of mental health treatment, offering new hope for individuals with depression, PTSD, addiction, and existential distress. Emerging research highlights the potential of psilocybin, MDMA, ketamine, and other substances to facilitate profound healing by enhancing neuroplasticity, disrupting maladaptive patterns, and fostering emotional breakthroughs.

Date: Saturday, April 18, 2026

Time: 4-6pm (EDT)

CEUs: 2

Format: Live on Zoom

Join us for an in-depth discussion on the neurobiology, clinical protocols, and policy implications of psychedelic-assisted therapy. We will explore:

✔ How Psychedelics Work – The science behind serotonin modulation, neuroplasticity, and fear extinction.

✔ Clinical Applications – The latest research on psilocybin for depression, MDMA for PTSD, and ketamine for suicidality.

✔ Ethical & Safety Considerations – The importance of set, setting, informed consent, and long-term monitoring.

✔ Policy & Future Directions – The path toward FDA approval, decriminalization efforts, and healthcare integration.

As the field advances, a balanced and ethical approach is essential to ensure accessibility, safety, and responsible use. Whether you are a clinician, researcher, or simply curious, this event will provide valuable insights into the future of psychedelics in medicine.

Let’s explore the potential of psychedelics to revolutionize mental health care—safely, ethically, and effectively.